Table 2.
Regression modelling results, including slopes, significance levels and E-values for alcohol–cancer relationships.
| Cancer | β-Estimate | Std. Error | p-Value | P. Adj. Holm | E-Value Estimate | Lower Bound E-Value |
|---|---|---|---|---|---|---|
| Oesophagus | 0.1388 | 0.0059 | 5.92 × 10−108 | 2.43 × 10−106 | 1.80 | 1.75 |
| All Cancers | 0.0888 | 0.0069 | 3.72 × 10−34 | 1.12 × 10−32 | 1.85 | 1.74 |
| Cervix | 0.1395 | 0.0060 | 1.39 × 10−105 | 5.56 × 10−104 | 1.79 | 1.74 |
| Prostate | 0.0950 | 0.0048 | 1.12 × 10−78 | 4.36 × 10−77 | 1.70 | 1.64 |
| Lung | 0.0663 | 0.0036 | 3.94 × 10−69 | 1.50 × 10−67 | 1.66 | 1.60 |
| All Cancers nNMSC | 0.0456 | 0.0032 | 4.20 × 10−44 | 1.47 × 10−42 | 1.58 | 1.52 |
| Kidney | 0.0750 | 0.0054 | 3.29 × 10−42 | 1.12 × 10−40 | 1.54 | 1.48 |
| Leukaemia—Lymphoid | 0.0547 | 0.0091 | 4.19 × 10−09 | 9.63 × 10−08 | 1.61 | 1.46 |
| Ovary | 0.0652 | 0.0049 | 6.49 × 10−38 | 2.08 × 10−36 | 1.52 | 1.46 |
| Stomach | 0.0711 | 0.0064 | 1.65 × 10−27 | 4.62 × 10−26 | 1.45 | 1.40 |
| Pancreas | 0.0547 | 0.0051 | 2.34 × 10−26 | 6.31 × 10−25 | 1.45 | 1.39 |
| Breast | 0.0771 | 0.0104 | 1.82 × 10−13 | 4.72 × 10−12 | 1.34 | 1.28 |
| Larynx | 0.0332 | 0.0054 | 1.05 × 10−9 | 2.52 × 10−8 | 1.31 | 1.24 |
| Leukaemia—Myeloid | 0.0517 | 0.0163 | 0.0017 | 0.0284 | 1.38 | 1.21 |
| Anus | 0.0143 | 0.0038 | 0.0002 | 0.0036 | 1.25 | 1.16 |
| Leukaemia | 0.0305 | 0.0083 | 0.0003 | 0.0051 | 1.23 | 1.15 |
| Corpus Uteri | 0.0290 | 0.0080 | 0.0003 | 0.0061 | 1.22 | 1.14 |
| Penis | 0.0109 | 0.0038 | 0.0036 | 0.0542 | 1.21 | 1.11 |
| Melanoma | 0.0138 | 0.0059 | 0.0200 | 0.2398 | 1.17 | 1.06 |
| Vulva and Vagina | 0.0048 | 0.0044 | 0.2774 | 1.0000 | 1.12 | 1.00 |
| Non-Hodgkin’s Lymphoma | 0.0067 | 0.0046 | 0.1458 | 1.0000 | 1.13 | 1.00 |
| Vulva | 0.0104 | 0.0190 | 0.5831 | 1.0000 | 1.19 | 1.00 |
| Oropharynx_Broad | 0.0152 | 0.0166 | 0.3621 | 1.0000 | 1.20 | 1.00 |
| Vagina | 0.0151 | 0.0097 | 0.1221 | 1.0000 | 1.37 | 1.00 |
| Colorectum | −0.0009 | 0.0036 | 0.7948 | 1.0000 | 1.05 | - |
| Brain | −0.0113 | 0.0049 | 0.0216 | 0.2398 | 1.17 | - |
| Non-Seminoma | −0.0316 | 0.4242 | 0.9411 | 1.0000 | 1.17 | - |
| Testis | −0.0106 | 0.0043 | 0.0130 | 0.1825 | 1.19 | - |
| Myeloma | −0.0172 | 0.0035 | 9.02 × 10−7 | 1.98 × 10−5 | 1.29 | - |
| Hepatocellular | −0.0232 | 0.0170 | 0.1779 | 1.0000 | 1.41 | - |
| Liver | −0.0749 | 0.0061 | 5.30 × 10−33 | 1.54 × 10−31 | 1.54 | - |
| Bladder | −0.0678 | 0.0046 | 5.27 × 10−47 | 1.90 × 10−45 | 1.56 | - |
| Hodgkin’s | −0.0425 | 0.0032 | 8.56 × 10−38 | 2.65 × 10−36 | 1.56 | - |
| Gallbladder and Biliary | −0.0721 | 0.0053 | 8.46 × 10−39 | 2.79 × 10−37 | 1.60 | - |
| Ovarian Dysgerminoma | −0.0102 | 0.0143 | 0.4840 | 1.0000 | 1.64 | - |
| Kaposi | −0.0430 | 0.0179 | 0.0174 | 0.2260 | 1.65 | - |
| Mesothelioma | −0.1087 | 0.0353 | 0.0024 | 0.0382 | 1.69 | - |
| Oropharynx | −0.2054 | 0.0290 | 6.49 × 10−12 | 1.62 × 10−10 | 1.70 | - |
| Thyroid | −0.1136 | 0.0063 | 3.01 × 10−66 | 1.11 × 10−64 | 1.72 | - |
| Medulloblastoma | −0.0374 | 0.0272 | 0.1908 | 1.0000 | 2.43 | - |
| Seminoma | −0.0882 | 0.0250 | 0.0011 | 0.0203 | 3.01 | - |
Table key: β-Estimate—estimate of the regression coefficient; Std. Error—standard error of the regression coefficient; p-value—significance level; P. Adj. Holm—p-value adjusted for multiple testing by the method of Holm; E-value—expected value required of some unknown confounder covariate with both the exposure and the outcome to explain the observed effect; lower bound of the E-value—the 95% lower bound of the confidence interval of the E-value.